Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
by Julio G. Martinez-Clark
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·123 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 12 epsHost
Recent guests
Recent episodes
Daniel Chen, Founder and CEO at Synthetic Design Lab
Jun 15, 2026
53m 35s
Shareef Mahdavi, Founder at PX Movement
Jun 5, 2026
55m 38s
Joseph Geraci, CSO/CTO & Co-Founder at NetraMark
May 15, 2026
51m 11s
Gary Zammit, President & CEO at Clinilabs Drug Development Corporation
Apr 17, 2026
46m 08s
Joseph Grieco, VP at Tris Pharma & Liza Micioni, Sr. Director at Tris Pharma
Apr 10, 2026
53m 19s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/15/26 |  Daniel Chen, Founder and CEO at Synthetic Design Lab | In this episode of Global Trial Accelerators, we speak with Daniel S. Chen, MD, PhD, Founder and CEO of Synthetic Design Lab and former Global Head of Cancer Immunotherapy Development at Genentech/Roche. Daniel shares insights from his pioneering work in cancer immunotherapy, the development of breakthrough therapies such as atezolizumab, and the future of oncology innovation. We also discuss the Cancer-Immunity Cycle, translational science, and what it takes to accelerate the path from disco... | 53m 35s | ||||||
| 6/5/26 |  Shareef Mahdavi, Founder at PX Movement✨ | patient experiencepractice growth+3 | Shareef Mahdavi | Laser Eye Center of Silicon Valley | — | patient experiencepractice growth+3 | — | 55m 38s | |
| 5/15/26 |  Joseph Geraci, CSO/CTO & Co-Founder at NetraMark✨ | artificial intelligencemedicine+3 | Joseph Geraci | NetraMarkDARPA+1 | — | artificial intelligenceclinical research+3 | — | 51m 11s | |
| 4/17/26 |  Gary Zammit, President & CEO at Clinilabs Drug Development Corporation✨ | life sciencesCNS+3 | Gary K. Zammit | Beyond the ScienceClinilabs Drug Development Corporation+5 | — | drug developmentclinical research+1 | — | 46m 08s | |
| 4/10/26 |  Joseph Grieco, VP at Tris Pharma & Liza Micioni, Sr. Director at Tris Pharma✨ | clinical developmentneurological disorders+2 | Joseph GriecoLiza Micioni | Tris Pharma | — | clinical programsinnovative solutions+2 | — | 53m 19s | |
| 3/27/26 |  Robert Packard, President at Medical Device Academy, Inc✨ | Quality and Regulatory AffairsMedical Device Industry+3 | Robert Packard | Medical Device Academy, Inc.Quality and Regulatory Affairs+1 | — | medical devicesbiotech+3 | — | 52m 50s | |
| 3/20/26 |  Kristen Mittal, Co-founder and CEO of Mittal Consulting✨ | regulatory affairsmedical devices+3 | Kristen Mittal | Mittal ConsultingFDA | — | regulatory strategymedical device innovators+3 | — | 36m 48s | |
| 3/13/26 |  Tina Soulis, Founder and Director at Alithia Life Sciences✨ | clinical researchbiotechnology+3 | A Prof Tina Soulis | Alithia Life Sciencesthe University of Melbourne+1 | — | clinical trialsCRO+3 | — | 32m 24s | |
| 3/6/26 |  Gregory Mark Hill, Managing Partner at GCH Partners✨ | investmententrepreneurship+3 | Gregory Mark Hill | GCH Partners | New YorkSilic | GCH Partnersfamily offices+3 | — | 1h 00m 47s | |
| 2/20/26 |  David Albert, Founder at AliveCor Inc✨ | digital cardiologymedical technology+3 | David E Albert Md | AliveCorAliveCor Inc.+1 | — | physician-inventorentrepreneur+2 | — | 51m 06s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/30/26 |  Alfonso García, CEO & BD Director at Leon Research✨ | leadershipclinical research+2 | Alfonso García | Leon ResearchAICROS | — | clinical investigationpsychology+1 | — | 46m 46s | |
| 1/16/26 |  Steven Collens, CEO at MATTER✨ | healthcareinnovation+2 | Steven Collens | MATTER | — | healthcare incubatoraccelerator-as-a-service+1 | — | 53m 00s | |
| 1/9/26 |  Pablo Yarza, Founder & CEO att Bioinfile✨ | bioinformaticsdata curation+1 | Pablo Yarza | BIOINFILBioinfile | — | data qualityresearch development+1 | — | 39m 39s | |
| 12/19/25 |  Scott Stout, CEO & Co-Founder at MedVector Clinical Trials | This episode features Scott Stout, who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and more diverse patient populations for clinical trial sites. Their approach allows trusted healthcare providers and their patients to benefit from clinical trials as a care option—without requiring physicians to become investigators or risking patient leakage. By aligning p... | 36m 09s | ||||||
| 12/12/25 |  Matteo Talotta, Director of Clinical Solutions at Biorce | This episode features Matteo Talotta, a global leader with experience across banking, academia, government, and a wide range of organizations — from start-ups and scale-ups to large multinationals. After working in Canada, Italy, the U.S., Spain, and Romania, Matteo brings a rich, multicultural perspective to the world of clinical innovation. Fluent in four languages and driven by collaboration, his career has led him to focus on the transformative power of AI in biotechnology. He is currentl... | 30m 19s | ||||||
| 12/5/25 |  Sonal Pendharkar Kulkarni, Co-founder & CSO at Uvisa Health | In this episode, we’re joined by Sonal Pendharkar Kulkarni, Ph.D., Co-founder and Chief Science Officer at Uvisa Health. With a background that bridges women’s health, the microbiome, digital health innovation, and medical device development, Sonal is at the forefront of creating smarter, science-driven solutions for vaginal health management. Sonal shares her journey from research scientist to entrepreneur, the insights that shaped Uvisa Health’s mission, and the importance of designing prod... | 27m 14s | ||||||
| 10/30/25 |  David Kraemer, Founder & Managing Member at 10 || 2 Capital Partners | In this episode, we sit down with David M. Kraemer, Founder of a boutique investment bank and former Vice President at Merrill Lynch and Wilshire Consulting. With deep experience across public and private markets, David shares insights on capital formation, innovation, and navigating complex investment landscapes. From biotech and MedTech to AI, robotics, and venture capital, his perspective bridges finance and technology in today’s fast-changing world. Tune in to hear how he’s built gl... | 30m 38s | ||||||
| 10/10/25 |  Joseph Palumbo, Head of R&D & Chief Medical Officer at BioVie Inc | Today we’re joined by Dr. Joseph M. Palumbo, a physician-scientist, mentor, and therapeutics developer with more than three decades of leadership in psychiatry, neurology, and neurodegenerative research. Dr. Palumbo has led groundbreaking work across the full R&D spectrum—from preclinical innovation to global drug approvals—advancing programs valued at over $1 billion. He has held senior leadership roles as Global Head of Psychiatry at Johnson & Johnson, Vice President & Fel... | 36m 20s | ||||||
| 9/26/25 |  Nicholas Kadysh, CEO at PharmAla Biotech | In this episode, we welcome Nicholas Kadysh, CEO of PharmAla Biotech, the company pioneering GMP MDMA production and named the top-performing stock on the Canadian capital markets in 2023 by The Market Herald. As Chair of Psychedelics Canada, Nicholas has been instrumental in advancing legal and ethical standards, building strong relationships with government, and shaping a regulatory landscape where healthcare innovation can thrive. His leadership has also been recognized by The Peak, ... | 32m 51s | ||||||
| 9/19/25 |  Carolina Alarco, Founder & Principal, Bio Strategy Advisors | In this episode, we sit down with Carolina [Last Name], a senior biotech executive with over 25 years of experience in the biopharmaceutical industry. Carolina is the Founder & Principal of Bio Strategy Advisors, serves on multiple biotech and nonprofit boards, and is the Co-Founder & Co-Chair of Latinos in Bio. She shares insights from her leadership journey at companies like Genzyme, Aegerion Pharmaceuticals, and Novelion Therapeutics, and discusses the future of biotech, the ... | 37m 17s | ||||||
| 9/12/25 |  Jason Hurt, Founder & CEO of Theragnostic Insights | In this episode, we are joined by Dr. Jason Hurt, a clinician-scientist and entrepreneur with extensive experience in radiopharmaceutical development, clinical trial strategy, and oncology drug development. In March 2025, Dr. Hurt founded Theragnostic Insights, a consulting and strategic advisory firm focused on advancing theranostic solutions and radioligand therapies—pioneering approaches that are shaping the future of cancer treatment. | 25m 02s | ||||||
| 9/5/25 |  Martin Schiller, Founder & CEO of Heligenics Inc | In this episode, we sit down with Dr. Martin R. Schiller, Prabhu Endowed Professor at UNLV, Founding Director of the Nevada Institute of Personalized Medicine, and founder of Heligenics Inc. Dr. Schiller shares his journey from academia to entrepreneurship, the breakthroughs behind the GigaAssay technology, and how personalized medicine is shaping the future of healthcare. Tune in to learn how cutting-edge research in genomics and biotechnology is being translated into real-world ... | 32m 38s | ||||||
| 8/29/25 |  Ross Youngs, Founder & CEO of Biosortia | Today’s guest is Ross O. Youngs, Founder and CEO, with over 35 years of experience inventing products, technologies, and processes across multiple industries. He holds more than 75 patents worldwide and is driven by a passion for creating innovations that are better, faster, and more cost-effective. His recent accomplishments include winning an R&D 100 Award for his work in biopolymer technologies. In 2009, his company Biosortia was awarded a $6 million ARPA-E grant from the U.S. De... | 29m 44s | ||||||
| 8/22/25 | Gianluca Fontana, CEO & Co-Founder of Prova Health | Today we’re joined by Gianluca Fontana, CEO and Co-Founder of Prova Health—the London-based advisory firm helping digital health and life sciences innovators prove their value with rock-solid clinical and economic evidence. With a background as a McKinsey consultant and Deputy Director at Imperial College London’s Institute of Global Health Innovation, Gianluca has led billion-pound research programs like the NHS Digital Academy and the REACT COVID-19 study. His published work on digital heal... | 36m 37s | ||||||
| 8/15/25 | Justin Chickles, CEO & Co-Founder of Glycyx Therapeutics | Could opioids be silently undermining cancer immunotherapy? This week, Justin Chickles — CEO and co-founder of Glycyx Therapeutics — explains how his team is tackling this overlooked challenge with axelopran, a breakthrough therapy now advancing to Phase 2 trials. From his early career at Johnson & Johnson to leading multiple startups, Justin offers a rare, insider’s perspective on driving biotech innovation from concept to clinic. If you’re interested in cutting-edge oncology, translat... | 40m 12s | ||||||
Showing 25 of 126
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.